Recent Finacing
Recent Raise
Dimension Therapeutics develops liver-directed AAV gene therapies for rare metabolic and genetic disorders, advancing IND-enabling and clinical-stage programs (including hemophilia B/A) with preferred access to REGENXBIO vectors.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
